Maltodextrin
processed starch
Ubiquitous starch-derived filler with a high glycemic punch and an unsettled gut-barrier signal
Mixed evidence
🍬Sweeteners & Additives
Evidence tier
Mixed
Research weight
Citations
12 verified / 12
Classification
Sweeteners & Additives
❝
What the evidence says. Conflicting results across studies; benefit uncertain.
What is Maltodextrin?
Maltodextrin (processed starch) is a sweetener or food additive used for bulking agent and texture/body builder in low-fat, powdered, and reduced-sugar products. NutriDex grades the human evidence as Mixed. Maltodextrin is a non-sweet, easily digestible carbohydrate made by partial hydrolysis of corn, potato, rice, or wheat starch into short glucose chains (dextrose equivalent under 20). It is one of the most common processed-food ingredients in the world, used as a bulking agent, thickener, carrier, and sports-energy carbohydrate, and is GRAS in the US (21 CFR 184.1444) with no numerical ADI assigned by FDA, EFSA, or JECFA because it is metabolized like ordinary starch. For the general population the weight of human evidence is reassuring at dietary levels, but it is metabolically a rapidly absorbed glucose source (glycemic index roughly 85-105, higher than table sugar), and a body of mechanistic and animal work has raised a still-unresolved signal about effects on the intestinal mucus barrier and bacterial adhesion relevant to inflammatory bowel disease.
Purported Benefits
✓Bulking agent and texture/body builder in low-fat, powdered, and reduced-sugar products
✓Carrier and spray-drying aid for flavors, colors, sweeteners, and supplements
✓Fast-absorbing, low-osmolality energy carbohydrate for endurance/sports drinks and gels
✓Improves solubility, mouthfeel, and freeze-thaw stability
✓Provides ~4 kcal/g; effectively a digestible glucose polymer (NOT a zero-calorie or non-glycemic ingredient)
Dosing & Compounds
Typical Dose
FDA: Generally Recognized as Safe (GRAS) under 21 CFR 184.1444, with no maximum level and no numerical ADI. EFSA and JECFA: no numerical ADI required (acceptable daily intake 'not specified'), as it is digested and absorbed as glucose like other starches. Wheat-derived maltodextrin must be declared as a gluten source in the EU; refined products are generally below the 20 ppm gluten threshold.
Active Compounds
Safety & Cautions
At normal dietary levels maltodextrin is not a recognized toxicity or cancer hazard, and no regulator has restricted it. The honest caveats are metabolic and gastrointestinal. Metabolically it behaves as rapidly digestible glucose with a glycemic index higher than sucrose, so it raises blood glucose and is not 'sugar-free' in any physiological sense — a concern for people with diabetes or insulin resistance despite 'no added sugar' labeling. The most studied signal is gut-related: Nickerson 2012 showed maltodextrin enhances adhesion of Crohn's-associated adherent-invasive E. coli to intestinal epithelium via type-1 pili, and Laudisi 2019 showed dietary maltodextrin induces endoplasmic-reticulum stress in goblet cells, depletes the protective Muc2 mucus layer, and worsens chemically induced colitis in mice. These are predominantly mechanistic/animal/in-vitro findings; robust human outcome data are lacking, and gastroenterology consensus is that this warrants caution and further study for people with IBD rather than avoidance by the general public. Large doses can cause osmotic GI symptoms (bloating, gas, loose stools), and wheat-derived product is relevant to celiac/gluten-sensitive individuals. Educational only — always check with your doctor or pharmacist before combining Maltodextrin with any medicine.
Key Studies ★ 12 studies
Meta-analysis
Rudiansyah 2025
✓ Full text
Systematic review and meta-analysis of RCTs in type 2 diabetes found resistant dextrin supplementation significantly lowered HbA1c (WMD approximately -0.30%) versus control, with effects on fasting glucose and insulin (moderate-quality evidence).
systematic review
Almeida 2020, Compr Rev Food Sci Food Saf
✓ Full text
Systematic review of human and animal studies found the majority reporting maltodextrin effects on gut microbiota and barrier function, but concluded human evidence remains insufficient to establish clinical harm at dietary intakes.
Systematic review
Eur J Nutr (systematic review) 2022
✓ Source
Systematic review of placebo-controlled trials (70 RCTs analyzed from 216 studies) found 60% reported maltodextrin-induced physiological effects, challenging its validity as an inert placebo and indicating direct effects on human gut physiology.
regulatory review
EFSA Panel (NDA/ANS) carbohydrate review
✓ Source
Maltodextrin is digested and absorbed as glucose in the small intestine, contributing ~4 kcal/g and behaving glycemically like other rapidly available carbohydrates rather than as fiber.
RCT
Lansink 2024
✓ Full text
Double-blind crossover RCTs in healthy individuals, people with obesity, and people with type 2 diabetes showed the slowly digestible carbohydrate oligomalt produced lower postprandial glucose iAUC and 38-60% lower insulin response than maltodextrin across all populations.
RCT
Baljon 2022
✓ Full text
Double-blind, randomized, crossover trial in healthy adults found resistant maltodextrin increased fecal bifidobacteria counts and stool wet weight, indicating prebiotic-type modulation of beneficial gut bacteria.
RCT
Tanaka 2022
✓ Full text
24-week randomized, double-blind, placebo-controlled trial in 29 Japanese subjects with HbA1c >6% found resistant maltodextrin reduced virulent gut metabolites and increased fecal Fusicatenibacter saccharivorans approximately two-fold.
regulatory
FDA 21 CFR 184.1444
✓ Source
Affirms maltodextrin (DE <20, from corn/potato/rice starch) as GRAS with no quantitative use limit, used per good manufacturing practice.
animal
Zangara 2022, Front Immunol
✓ Source
Maltodextrin impaired the intestinal mucus barrier and accelerated colitis in mice through direct actions on the epithelium, independent of broad microbiota shifts.
mechanistic / animal
Nickerson 2015, Gut Microbes
✓ Source
Maltodextrin suppressed cellular antibacterial responses and impaired mucosal clearance of Salmonella, deregulating intestinal anti-microbial defense in cell and mouse models.
animal
Laudisi 2019, Cell Mol Gastroenterol Hepatol
✓ Source
Dietary maltodextrin (5%) induced goblet-cell ER stress, Muc2 mucus depletion, and exacerbated DSS colitis in mice; the ER-stress inhibitor TUDCA reversed the effect.
in vitro / mechanistic
Nickerson 2012, PLOS ONE
✓ Full text
Maltodextrin enhanced Crohn's-associated adherent-invasive E. coli adhesion to intestinal epithelial cells via type-1 pili and increased biofilm formation, independent of CEACAM6.